View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 28, 2020updated 18 Sep 2020 5:13pm

Pharma FDI in the times of Covid-19: A challenging pill to swallow

By Duncan West

Political and economic stability, and a coherent Covid-19 containment strategy are among the key factors in attracting biopharma FDI. With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector will strongly depend on countries’ ability to respond to the epidemic, and their overall stability.

Read more here


In advance of the launch of our FDI-focused site, please complete the following survey aimed at investigating how investment plans are changing in the wake of Covid-19.

Your participation is confidential and the survey will take no longer than 5-10 minutes to complete. As a thank you we will share a copy of the survey write up with you.


Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU